You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sundy J, Gansen N, Kelly S, et al
FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment
Annals of the Rheumatic Diseases 2013;71:446.